Our recent publication in Biosensors and Bioelectronics with the University of Wisconsin was discussed in an article published by Inside...

Capio Biosciences Korea is one of four companies selected to receive support from Hongcheon-gun to open a second office within the...

Capio Biosciences and BioView have launched a $2.18M project to advance the use of liquid biopsy for head and neck cancer. The project is...

The article describes our work to develop a liquid biopsy alongside other companies and laboratories in Madison and at the University of...

GenomeWeb.com highlights our new collaboration with BioView for imaging and image analysis.

Seungpyo Hong, PhD, was named the Milton J. Henrichs Chair of Pharmaceutical Sciences in May. A recent article from the University of...

On July 1, Seungpyo Hong, PSD Professor, Director of Wisconsin Center for NanoBioSystems and cofounder of Capio Biosciences, will become...

Professor Seungpyo Hong's work with Capio Biosciences is one of six faculty projects getting a boost from State Economic Engagement and...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for U.S. Patent Application Serial No.: 15/123,156 -...

Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for patent application # 10-2017-7035887 - "Method...

We are very excited that Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, U. of North Carolina and Cofounder of Capio...

Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for...

Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving...

Michael Poellmann presented "Quantification and downstream analysis of circulating tumor cells isolated using CapioCyte(TM) liquid...

Capio Biosciences "CapioCyte(TM) technology is featured in this article by John Gilmore of Genome web. https://www.genomeweb.com/cancer/c...

Capio Biosciences, an early stage biotechnology startup company developing a biopsy-free technology for capturing Circulating Tumor Cells...

BUILDING A MOLECULAR DIAGNOSTICS STARTUP FROM THE GROUND UP Download PDF

Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both...

Seungpyo Hong presented Enhanced Sensitivity of Specificity of Circulating Tumor Cell Capture Using a Synergistic Combination of Cell...